Abstract:Background CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). Methods To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. Findings In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Interpretation Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population. CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population.

Association of Genetic Polymorphisms in HSD17B1, HSD17B2 and SHBG Genes with Hepatocellular Carcinoma Risk

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

P0162 CYP1B1 Polymorphisms and Hepatocellular Cancer Risk in a Chinese Population

Interaction Analysis of SHMT1/2 Gene Variants with HCC in Chinese Patients

Common Genetic Variations Of The Cytochrome P450 1a1 Gene And Risk Of Hepatocellular Carcinoma In A Chinese Population

Association Between P2rx7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in A Chinese Han Population

Single Nucleotide Polymorphisms in Telomere Length-Related Genes Are Associated with Hepatocellular Carcinoma Risk in the Chinese Han Population

Genetic Polymorphism of Epidermal Growth Factor Rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population:

Estrogen Receptor Α Polymorphisms Associated with Susceptibility to Hepatocellular Carcinoma in Hepatitis B Virus Carriers

Breast Cancer Risk-Associated Variants at 6q25.1 Influence Risk of Hepatocellular Carcinoma in a Chinese Population.

Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.

Association between single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and susceptibility to hepatocellular carcinoma in a Chinese population.

Association Of Tnf-Alpha Genetic Polymorphisms With Hepatocellular Carcinoma Susceptibility: A Case-Control Study In A Han Chinese Population

Association between polymorphism of the cyclin E1 gene and susceptibility to hepatocellular carcinoma in Chinese Han population of Hubei

Mir-146a Genetic Polymorphism Contributes To The Susceptibility To Hepatocellular Carcinoma In A Chinese Population

Association of Cyp1a2 Genetic Polymorphisms with Hepatocellular Carcinoma Susceptibility: A Case-Control Study in A High-Risk Region of China

Association of a functional intronic polymorphism rs 735396 in HNF 1 A gene with the susceptibility to hepatocellular carcinoma in Han Chinese population

Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.

Impacts of TCF7L2 Gene Polymorphisms on the Susceptibility of Hepatogenous Diabetes and Hepatocellular Carcinoma in Cirrhotic Patients

Htert Rs2736098 Genetic Variants and Susceptibility of Hepatocellular Carcinoma in the Chinese Population: a Case-Control Study